BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7044291)

  • 1. Antibacterial properties of alafosfalin combined with cephalexin.
    Atherton FR; Hall MJ; Hassall CH; Holmes SW; Lambert RW; Lloyd WJ; Nisbet LJ; Ringrose PS; Westmacott D
    Antimicrob Agents Chemother; 1981 Oct; 20(4):470-6. PubMed ID: 7044291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The fractional inhibitory concentration (FIC) index as a measure of synergy.
    Hall MJ; Middleton RF; Westmacott D
    J Antimicrob Chemother; 1983 May; 11(5):427-33. PubMed ID: 6874629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro potentiation of cephalosporins by alafosfalin against urinary tract bacteria.
    Arisawa M; Ohshima J; Ohsawa E; Maruyama HB
    Antimicrob Agents Chemother; 1982 May; 21(5):706-10. PubMed ID: 7103452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alafosfalin, a new inhibitor of cell wall biosynthesis: in vitro activity against urinary isolates in Japan and potentiation with beta-lactams.
    Maruyama HB; Arisawa M; Sawada T
    Antimicrob Agents Chemother; 1979 Oct; 16(4):444-51. PubMed ID: 518073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysis enhancement: a novel form of interaction between beta-lactam antibiotics.
    Greenwood D; O'Grady F
    J Med Microbiol; 1975 Feb; 8(1):205-8. PubMed ID: 1092867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effect of cephalexin with mecillinam.
    Otsuki M
    J Antibiot (Tokyo); 1981 Jun; 34(6):739-52. PubMed ID: 6268594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphonopeptide antibacterial agents related to alafosfalin: design, synthesis, and structure-activity relationships.
    Atherton FR; Hall MJ; Hassall CH; Holmes SW; Lambert RW; Lloyd WJ; Ringrose PS
    Antimicrob Agents Chemother; 1980 Dec; 18(6):897-905. PubMed ID: 7016027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic antibacterial activity between L-norvalyl-L-1-aminoethylphosphonic acid and nocardicin A.
    Angehrn P; Hall MJ; Lloyd WJ; Westmacott D
    Antimicrob Agents Chemother; 1984 May; 25(5):607-11. PubMed ID: 6428312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial activity of tobramycin against gram-negative bacteria and the combination of ampicillin/tobramycin against E. coli.
    Laxer RM; Mackay E; Marks MI
    Chemotherapy; 1975; 21(2):90-8. PubMed ID: 168040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Electron microscopic study of the combined action of ampicillin and cephalexin on E. coli].
    Chavdarova V; Cherepanova N; Kharizanova T; Avramova R
    Antibiotiki; 1977 Jun; 22(6):536-9. PubMed ID: 329750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combined antimicrobial action of mecillinam and ampicillin].
    Khantimer EI
    Antibiotiki; 1983 Aug; 28(8):589-91. PubMed ID: 6314880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of cell lysis in Escherichia coli: cooperative effect of nocardicin A and mecillinam.
    Berenguer J; de Pedro MA; Vázquez D
    Antimicrob Agents Chemother; 1982 Feb; 21(2):195-200. PubMed ID: 6280596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphologic changes produced by amdinocillin alone and in combination with beta-lactam antibiotics: in vitro and in vivo.
    Kramer MJ; Mauriz YR; Timmes MD; Robertson TL; Cleeland R
    Am J Med; 1983 Aug; 75(2A):30-41. PubMed ID: 6311003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of antibacterial activity of mecillinam against recently isolated bacilli of 5 genera of Enterobacteriaceae from clinical materials with ampicillin, amoxicillin, cephalexin, nalidixic acid and pipemidic acid (author's transl)].
    Kosakai N; Oguri T
    Jpn J Antibiot; 1979 Aug; 32(8):812-8. PubMed ID: 226736
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of mecillinam on peptidoglycan synthesis during the division cycle of Salmonella typhimurium 2616.
    Licht J; Gally D; Henderson T; Young K; Cooper S
    Res Microbiol; 1993; 144(6):423-33. PubMed ID: 8190989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of alafosfalin, alone and in combination with cephalexin, in humans.
    Allen JG; Lees LJ
    Antimicrob Agents Chemother; 1980 Jun; 17(6):973-9. PubMed ID: 7406481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of ampicillin and cefazolin combined with mecillinam (author's transl)].
    Stille W; Bischof-Léger E; Helm EB
    Arzneimittelforschung; 1978; 28(10):1661-4. PubMed ID: 226099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivities of strains of enteropathogenic Escherichia coli to cephalexin and other antibiotics.
    Konforti N; Halperin E
    Am J Clin Pathol; 1975 Jul; 64(1):121-6. PubMed ID: 1098437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergic post-antibiotic effect of mecillinam, in combination with other beta-lactam antibiotics in relation to morphology and initial killing.
    Hanberger H; Nilsson LE; Svensson E; Maller R
    J Antimicrob Chemother; 1991 Oct; 28(4):523-32. PubMed ID: 1761447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphonopeptides Revisited, in an Era of Increasing Antimicrobial Resistance.
    Marrs ECL; Varadi L; Bedernjak AF; Day KM; Gray M; Jones AL; Cummings SP; Anderson RJ; Perry JD
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32210055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.